@misc{indiciae43cb1986fbec,
  title = {Efficacy and Safety of Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma: A Real-World Multicenter Observational Study.},
  author = {Krittiya Korphaisarn and Kosin Wirasorn and Suebpong Tanasanvimon and Kijjakom Thanasombunsukh and Kunlatida Maneenil and Jirawat Thanestada and Nattaya Teeyapun and Jarin Chindaprasirt and Chirawadee Sathitruangsak and Teerada Siripoon and Phannin Tiraswasdichai and Chanchai Charonpongsuntorn and Passakorn Wanchaijiraboon and Wannisa Laosuangkoon and Patrapim Sunpaweravong and Ekapop Sirachainan and Charuwan Akewanlop},
  year = {2026},
  doi = {10.32604/or.2026.083206},
  url = {https://pubmed.ncbi.nlm.nih.gov/42630704/},
  note = {Source identifier: 42630704}
}